{"id":752,"date":"2025-12-09T10:59:02","date_gmt":"2025-12-09T09:59:02","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/br\/?page_id=752"},"modified":"2025-12-09T10:59:02","modified_gmt":"2025-12-09T09:59:02","slug":"relatorio-de-informacao-nao-financiera-einf","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/","title":{"rendered":"Relatorio de informa\u00e7ao nao financiera einf"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"752\" class=\"elementor elementor-752\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d94c1f0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d94c1f0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7a3132e\" data-id=\"7a3132e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3399ab2 elementor-widget elementor-widget-text-editor\" data-id=\"3399ab2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Com o objetivo de cumprir a Lei 11\/2018 sobre informa\u00e7\u00e3o n\u00e3o financeira e diversidade, anualmente a Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora o seu Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira, seguindo as recomenda\u00e7\u00f5es e indica\u00e7\u00f5es estabelecidas pela referida Lei 11\/2018.<\/p><p>O relat\u00f3rio inclui informa\u00e7\u00f5es sobre quest\u00f5es ambientais, sociais e de pessoal, direitos humanos, combate \u00e0 corrup\u00e7\u00e3o e suborno e impacto da organiza\u00e7\u00e3o na sociedade. Para cada uma das quest\u00f5es, s\u00e3o descritas as pol\u00edticas e a\u00e7\u00f5es desenvolvidas, bem como os riscos identificados e decorrentes do desenvolvimento da atividade da empresa. O relat\u00f3rio foi elaborado de acordo com os princ\u00edpios de comparabilidade, fiabilidade, materialidade e relev\u00e2ncia estabelecidos na referida Lei 11\/2018.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c2df239 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c2df239\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cc5a766\" data-id=\"cc5a766\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-02d29a1 elementor-align-left elementor-widget elementor-widget-button\" data-id=\"02d29a1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131248\/informe-einf-laboratorios-lesvi-2022.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-download\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M216 0h80c13.3 0 24 10.7 24 24v168h87.7c17.8 0 26.7 21.5 14.1 34.1L269.7 378.3c-7.5 7.5-19.8 7.5-27.3 0L90.1 226.1c-12.6-12.6-3.7-34.1 14.1-34.1H192V24c0-13.3 10.7-24 24-24zm296 376v112c0 13.3-10.7 24-24 24H24c-13.3 0-24-10.7-24-24V376c0-13.3 10.7-24 24-24h146.7l49 49c20.1 20.1 52.5 20.1 72.6 0l49-49H488c13.3 0 24 10.7 24 24zm-124 88c0-11-9-20-20-20s-20 9-20 20 9 20 20 20 20-9 20-20zm64 0c0-11-9-20-20-20s-20 9-20 20 9 20 20 20 20-9 20-20z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\"> Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b79b42f elementor-align-left elementor-widget elementor-widget-button\" data-id=\"b79b42f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/07\/30110050\/informe-de-verificacion-einf-neuraxpharm-pharmaceuticals-s-l-u-2024.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-download\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M216 0h80c13.3 0 24 10.7 24 24v168h87.7c17.8 0 26.7 21.5 14.1 34.1L269.7 378.3c-7.5 7.5-19.8 7.5-27.3 0L90.1 226.1c-12.6-12.6-3.7-34.1 14.1-34.1H192V24c0-13.3 10.7-24 24-24zm296 376v112c0 13.3-10.7 24-24 24H24c-13.3 0-24-10.7-24-24V376c0-13.3 10.7-24 24-24h146.7l49 49c20.1 20.1 52.5 20.1 72.6 0l49-49H488c13.3 0 24 10.7 24 24zm-124 88c0-11-9-20-20-20s-20 9-20 20 9 20 20 20 20-9 20-20zm64 0c0-11-9-20-20-20s-20 9-20 20 9 20 20 20 20-9 20-20z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\"> Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-76bd738 elementor-align-left elementor-widget elementor-widget-button\" data-id=\"76bd738\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131241\/informe-einf-laboratorios-lesvi-2021.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-download\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M216 0h80c13.3 0 24 10.7 24 24v168h87.7c17.8 0 26.7 21.5 14.1 34.1L269.7 378.3c-7.5 7.5-19.8 7.5-27.3 0L90.1 226.1c-12.6-12.6-3.7-34.1 14.1-34.1H192V24c0-13.3 10.7-24 24-24zm296 376v112c0 13.3-10.7 24-24 24H24c-13.3 0-24-10.7-24-24V376c0-13.3 10.7-24 24-24h146.7l49 49c20.1 20.1 52.5 20.1 72.6 0l49-49H488c13.3 0 24 10.7 24 24zm-124 88c0-11-9-20-20-20s-20 9-20 20 9 20 20 20 20-9 20-20zm64 0c0-11-9-20-20-20s-20 9-20 20 9 20 20 20 20-9 20-20z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\"> Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Com o objetivo de cumprir a Lei 11\/2018 sobre informa\u00e7\u00e3o n\u00e3o financeira e diversidade, anualmente a Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora o seu Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira, seguindo as recomenda\u00e7\u00f5es e indica\u00e7\u00f5es estabelecidas pela referida Lei 11\/2018. O relat\u00f3rio inclui informa\u00e7\u00f5es sobre quest\u00f5es ambientais, sociais e de pessoal, direitos humanos, combate [&hellip;]<\/p>\n","protected":false},"author":2493,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-752","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Relatorio de informa\u00e7ao nao financiera einf - Neuraxpharm Brasil<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Relatorio de informa\u00e7ao nao financiera einf\" \/>\n<meta property=\"og:description\" content=\"Com o objetivo de cumprir a Lei 11\/2018 sobre informa\u00e7\u00e3o n\u00e3o financeira e diversidade, anualmente a Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora o seu Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira, seguindo as recomenda\u00e7\u00f5es e indica\u00e7\u00f5es estabelecidas pela referida Lei 11\/2018. O relat\u00f3rio inclui informa\u00e7\u00f5es sobre quest\u00f5es ambientais, sociais e de pessoal, direitos humanos, combate [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Brasil\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/relatorio-de-informacao-nao-financiera-einf\\\/\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/relatorio-de-informacao-nao-financiera-einf\\\/\",\"name\":\"Relatorio de informa\u00e7ao nao financiera einf - Neuraxpharm Brasil\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/#website\"},\"datePublished\":\"2025-12-09T09:59:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/relatorio-de-informacao-nao-financiera-einf\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/relatorio-de-informacao-nao-financiera-einf\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/relatorio-de-informacao-nao-financiera-einf\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Relatorio de informa\u00e7ao nao financiera einf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/#website\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/\",\"name\":\"Neuraxpharm Brasil\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.neuraxpharm.com\\\/br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Relatorio de informa\u00e7ao nao financiera einf - Neuraxpharm Brasil","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf","og_locale":"en_US","og_type":"article","og_title":"Relatorio de informa\u00e7ao nao financiera einf","og_description":"Com o objetivo de cumprir a Lei 11\/2018 sobre informa\u00e7\u00e3o n\u00e3o financeira e diversidade, anualmente a Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora o seu Relat\u00f3rio de informa\u00e7\u00e3o n\u00e3o financeira, seguindo as recomenda\u00e7\u00f5es e indica\u00e7\u00f5es estabelecidas pela referida Lei 11\/2018. O relat\u00f3rio inclui informa\u00e7\u00f5es sobre quest\u00f5es ambientais, sociais e de pessoal, direitos humanos, combate [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/","og_site_name":"Neuraxpharm Brasil","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/","url":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/","name":"Relatorio de informa\u00e7ao nao financiera einf - Neuraxpharm Brasil","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/br\/#website"},"datePublished":"2025-12-09T09:59:02+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/br\/relatorio-de-informacao-nao-financiera-einf\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.neuraxpharm.com\/br\/"},{"@type":"ListItem","position":2,"name":"Relatorio de informa\u00e7ao nao financiera einf"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/br\/#website","url":"https:\/\/www.neuraxpharm.com\/br\/","name":"Neuraxpharm Brasil","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/pages\/752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/users\/2493"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/comments?post=752"}],"version-history":[{"count":4,"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/pages\/752\/revisions"}],"predecessor-version":[{"id":756,"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/pages\/752\/revisions\/756"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/br\/wp-json\/wp\/v2\/media?parent=752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}